These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30816497)

  • 21. Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors.
    Franke NE; Kaspers GL; Assaraf YG; van Meerloo J; Niewerth D; Kessler FL; Poddighe PJ; Kole J; Smeets SJ; Ylstra B; Bi C; Chng WJ; Horton TM; Menezes RX; Musters RJ; Zweegman S; Jansen G; Cloos J
    Oncotarget; 2016 Nov; 7(46):74779-74796. PubMed ID: 27542283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane proteome analysis of glioblastoma cell invasion.
    Mallawaaratchy DM; Buckland ME; McDonald KL; Li CC; Ly L; Sykes EK; Christopherson RI; Kaufman KL
    J Neuropathol Exp Neurol; 2015 May; 74(5):425-41. PubMed ID: 25853691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion.
    Misek SA; Chen J; Schroeder L; Rattanasinchai C; Sample A; Sarkaria JN; Gallo KA
    Mol Cancer Res; 2017 Aug; 15(8):1085-1095. PubMed ID: 28487380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
    Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
    Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.
    Liu B; Dong H; Lin X; Yang X; Yue X; Yang J; Li Y; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Mao S; Chen Q; Chang J
    Oncotarget; 2016 Dec; 7(50):82411-82423. PubMed ID: 27705942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MARCKS protein overexpression is associated with poor prognosis in male breast cancer.
    Manai M; Abdeljaoued S; Goucha A; Adouni O; Bettaieb I; Bouzaien H; Rahal K; Birnbaum D; Bertucci F; Gamoudi A
    Cancer Biomark; 2019; 26(4):513-522. PubMed ID: 31771045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers.
    Fong LWR; Yang DC; Chen CH
    Cancer Metastasis Rev; 2017 Dec; 36(4):737-747. PubMed ID: 29039083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
    Bo H; Fan L; Gong Z; Liu Z; Shi L; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li G; Xiong W; Zeng Z; Cao K; Zhang S; Xiong F
    Oncol Rep; 2019 Apr; 41(4):2431-2439. PubMed ID: 30816545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation.
    Ma YS; Wu ZJ; Bai RZ; Dong H; Xie BX; Wu XH; Hang XS; Liu AN; Jiang XH; Wang GR; Jiang JJ; Xu WH; Chen XP; Tan GH; Fu D; Liu JB; Liu Q
    Cancer Lett; 2018 Jun; 423():86-94. PubMed ID: 29548818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo.
    Rombouts K; Carloni V; Mello T; Omenetti S; Galastri S; Madiai S; Galli A; Pinzani M
    Cancer Lett; 2013 Jun; 333(2):244-52. PubMed ID: 23376641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
    Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
    Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation.
    Lu Y; Xiao L; Liu Y; Wang H; Li H; Zhou Q; Pan J; Lei B; Huang A; Qi S
    Autophagy; 2015; 11(12):2213-32. PubMed ID: 26553592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.
    Liu J; Chen SJ; Hsu SW; Zhang J; Li JM; Yang DC; Gu S; Pinkerton KE; Chen CH
    Theranostics; 2021; 11(9):4122-4136. PubMed ID: 33754052
    [No Abstract]   [Full Text] [Related]  

  • 36. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma.
    Chang L; Zhao D; Liu HB; Wang QS; Zhang P; Li CL; Du WZ; Wang HJ; Liu X; Zhang ZR; Jiang CL
    Mol Med Rep; 2015 Nov; 12(5):6702-10. PubMed ID: 26299938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2.
    Pang H; Zheng Y; Zhao Y; Xiu X; Wang J
    Biochem Biophys Res Commun; 2015 Dec; 468(4):739-45. PubMed ID: 26556542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
    Ji T; Zhang X; Li W
    Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
    Yang Z; Xu S; Jin P; Yang X; Li X; Wan D; Zhang T; Long S; Wei X; Chen G; Meng L; Liu D; Fang Y; Chen P; Ma D; Gao Q
    Oncotarget; 2016 Jun; 7(25):37649-37663. PubMed ID: 27081703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.